secwatch / observer

8-K filed May 29, 2026, 4:01 PM ET ticker ACMR CIK 0001680062

other material confidence high sentiment neutral materiality 0.65

ACM Shanghai board approves H-share listing on HKEX Main Board, up to 7% of share capital

ACM Research, Inc.

Board of ACM Shanghai (subsidiary of ACMR) approved H-share offering and listing on HKEX Main Board.
Proposed issuance of H shares up to 7% of total share capital post-offering, with 15% over-allotment option.
Use of proceeds: product development, R&D, global expansion, working capital, and loan repayment.
Listing subject to shareholder approval and regulatory clearances from CSRC, SEHK, SFC.
Resolution validity period of 24 months from shareholder approval, extendable if approvals obtained.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001140361-26-023310
form_type: 8-K
ticker: ACMR
cik: 0001680062
company_name: ACM Research, Inc.
filed_at: 2026-05-29T20:01:48+00:00
discovered_at: 2026-05-29T20:03:01.792372+00:00
generated_at: 2026-05-29T20:03:33.910159+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001140361-26-023310
json_url: https://secwatch.observer/filing/0001140361-26-023310.json
markdown_url: https://secwatch.observer/filing/0001140361-26-023310.md
text_url: https://secwatch.observer/filing/0001140361-26-023310.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1680062/000114036126023310/0001140361-26-023310-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1680062/000114036126023310/ef20075131_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

SYRE

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ORKA

Oruka Therapeutics expands ORKA-001 license to include IBD; clinical dosing restrictions until 2028-2030

Oruka Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Via Renewables to redeem all 1,884,935 shares of its 8.75% Series A Preferred at $25.00 per share plus dividends

Via Renewables, Inc. June 1, 2026, 3:06 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BUKS

CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP June 1, 2026, 12:41 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds

ClearSign Technologies Corp June 1, 2026, 8:30 AM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

UFPI

UFP Industries authorizes $300M share repurchase program, replacing prior authorization

UFP INDUSTRIES INC June 1, 2026, 8:17 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001140361-26-023310

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.